Form 4 for TXG 10x Genomics, Inc.
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-22 · accession 0001610717-24-000258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-23 | 2024-05-22 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $24.30 | -4,877 | 889.6K | -0.5% | -$118.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-22 | S | D | 4,877 | $24.30 | 889,641 | D | — | — |